V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033605 | 210013387 | 1.7 | 58.6 | Disease modification (D) | 2017-04-12 | 2017-10-08 | CARBOPLATIN + ETOPOSIDE | N | N | 210040419 | BEVACIZUMAB |
| 210033606 | 210031489 | 1.65 | 82.6 | Curative (C) | null | 2013-11-22 | UKALL XII Maintenance (3 months) | Y | N | 210040494 | METHOTREXATE HIGH DOSE |
| 210033607 | 210013397 | 0 | 45 | Curative (C) | 2019-11-03 | 2019-11-03 | Erwinase (Erwinia Asparaginase) | N | N | 210040510 | CHOP |
| 210033608 | 210013401 | 1.9 | 82.5 | null | 2014-01-08 | 2014-01-15 | UKALL XII Intensification | N | N | 210040523 | ERWINIA ASPARAGINASE |
| 210033609 | 210013415 | 0 | null | Palliative (P) | null | 2016-10-11 | CARBOPLATIN + VINCRISTINE | N | N | 210040618 | CARBOPLATIN + VINCRISTINE |
| 210033610 | 210013417 | null | 64 | Curative (C) | 2017-10-22 | 2017-10-29 | Methotrexate High Dose (3g/m2) | null | Y | 210040628 | RIALTO TRIAL |
| 210033611 | 210022420 | 1.17 | 86 | Curative (C) | 2017-03-08 | 2017-03-15 | Bendamustine +/- Prednisolone | N | N | 210040696 | CARBOPLATIN + ETOPOSIDE |
| 210033612 | 210013432 | null | null | null | 2016-09-14 | 2016-09-19 | CHOP - 21 days | 02 | N | 210040696 | CARBOPLATIN + ETOPOSIDE |
| 210033613 | 210013440 | 1.72 | null | Disease modification (D) | 2013-08-11 | 2014-01-13 | CARBOPLATIN + ETOPOSIDE | N | N | 210040728 | CARBOPLATIN + ETOPOSIDE |
| 210033614 | 210013459 | null | null | Disease modification (D) | 2018-01-12 | 2018-01-12 | Inotuzumab Ozogamicin | N | N | 210040847 | IDELALISIB |
| 210033615 | 210022435 | 0 | 16 | Adjuvant (A) | 2017-12-22 | 2019-03-17 | Methotrexate High Dose (3g/m2) | N | N | 210040871 | METHOTREXATE HIGH DOSE |
| 210033616 | 210013466 | null | 13.7 | Palliative (P) | 2013-09-17 | 2016-01-26 | Erwinase (Erwinia Asparaginase) | Y | null | 210040880 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210033617 | 210013469 | 1.87 | 29.2 | Palliative (P) | 2017-04-18 | 2017-04-21 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE | N | N | 210040886 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 210033618 | 210013477 | null | 62 | Curative (C) | 2013-07-28 | 2015-09-12 | CARBOPLATIN + VINORELBINE | N | null | 210040931 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210033619 | 210013481 | 1.7 | null | Adjuvant (A) | 2018-03-25 | 2018-03-26 | Vinorelbine (oral) | Y | N | 210040958 | PACKER MAINTENANCE |
| 210033620 | 210013490 | 1.87 | null | Curative (C) | 2018-02-07 | 2018-03-06 | ICE-R | Y | N | 210041016 | CVD |
| 210033621 | 210013491 | 1.54 | 39.2 | null | null | 2014-07-27 | ALL Int Guide B Int Maint Ph III | N | Y | 210041021 | LOMUSTINE + PROCARBAZINE + VINCRISTINE |
| 210033622 | 210013497 | 1.83 | 90.75 | Curative (C) | 2018-03-24 | 2018-11-12 | Ofatumumab Loading | Y | N | 210041034 | ICE-R |
| 210033623 | 210013506 | 1.65 | 74.3 | Palliative (P) | 2016-08-16 | 2016-08-21 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | Y | N | 210041101 | TAMIGA TRIAL |
| 210033624 | 210022459 | 1.8 | 70 | null | 2016-05-19 | 2016-05-19 | Abiraterone | N | N | 210041115 | BEVACIZUMAB + LOMUSTINE |
| 210033625 | 210013512 | null | 52 | Curative (C) | 2015-04-24 | 2015-04-24 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | Y | N | 210041122 | TRASTUZUMAB EMTANSINE |
| 210033626 | 210013518 | null | 77.7 | Curative (C) | null | 2017-11-18 | IRINOTECAN + TEMOZOLOMIDE | N | N | 210041191 | POMALIDOMIDE |
| 210033627 | 210013522 | 1.56 | 63.05 | null | 2018-01-25 | 2018-03-12 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | Y | N | 210041193 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210033628 | 210013527 | 1.75 | 88.4 | Curative (C) | 2019-02-25 | 2019-02-25 | Bevacizumab + Temozolomide | Y | N | 210041199 | BR14 TRIAL |
| 210033629 | 210013531 | null | 72 | Curative (C) | null | 2014-10-27 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | Y | N | 210041244 | BEVACIZUMAB + LOMUSTINE |
| 210033630 | 210013547 | 1.75 | 73 | Curative (C) | 2015-07-04 | 2016-03-06 | MELPHALAN | N | N | 210041346 | SIOP |
| 210033631 | 210022475 | 1.6 | null | Curative (C) | 2016-11-09 | 2016-11-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | 210041357 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210033632 | 210013562 | 1.8 | 70.7 | Neo-adjuvant (N) | 2014-09-30 | 2014-11-07 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | null | 210041423 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210033633 | 210033674 | null | 50 | Curative (C) | 2015-08-13 | 2015-11-08 | MELPHALAN | N | null | 210041470 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210033634 | 210038358 | 1.76 | null | Curative (C) | null | 2013-11-07 | Cytarabine intrathecal | Y | N | 210041615 | TAMIGA TRIAL |
| 210033635 | 210013590 | 1.6 | null | Adjuvant (A) | 2015-07-20 | 2016-09-21 | Alemtuzumab+Busulfan+CyclophosphMUD | N | N | 210041618 | BEVACIZUMAB + IRINOTECAN |
| 210033636 | 210013597 | null | 63 | Curative (C) | 2012-09-21 | 2015-07-03 | Gemcitabine + Oxaliplatin | N | N | 210041630 | GEMCARBO |
| 210033637 | 210013606 | 1.65 | 82.3 | Curative (C) | 2017-03-14 | 2017-04-07 | Irinotecan + Temozolomide | N | N | 210041679 | BEVACIZUMAB + IRINOTECAN |
| 210033638 | 210028109 | 1.66 | 66.5 | Curative (C) | null | 2018-09-12 | REGORAFENIB | N | N | 210041701 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210033639 | 210013614 | null | null | Palliative (P) | 2014-03-27 | 2014-03-29 | CYTARABINE + ETOPOSIDE | 02 | N | 210041789 | IRINOTECAN + TEMOZOLOMIDE |
| 210033640 | 210013615 | 1.57 | 60.7 | Curative (C) | 2014-08-11 | 2014-08-13 | Pemetrexed | 02 | N | 210041797 | FEC |
| 210033641 | 210013622 | 1.72 | null | Curative (C) | 2019-05-09 | 2019-05-22 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | 02 | N | 210041817 | CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 210033642 | 210013629 | 0 | 63.7 | null | 2016-03-22 | 2016-03-23 | DAUNORUBICIN + VINCRISTINE | Y | N | 210041854 | IRINOTECAN + TEMOZOLOMIDE |
| 210033643 | 210013631 | 1.7 | 70 | Curative (C) | 2016-01-27 | 2016-02-10 | Bortezomib (weekly) | N | N | 210041861 | CARBOPLATIN + PROCARBAZINE |
| 210033644 | 210028119 | 1.66 | 65.2 | Curative (C) | null | 2015-04-26 | FLAG | 99 | N | 210041872 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 210033645 | 210013641 | 1.75 | 41.4 | Curative (C) | 2015-12-23 | 2015-12-30 | Docetaxel 75mg/m2 (21 day) | N | N | 210041947 | IRINOTECAN + TEMOZOLOMIDE |
| 210033646 | 210013644 | 1.73 | null | null | 2018-02-28 | 2018-03-20 | Cytarabine HD + Methotrexate HD | N | null | 210041983 | CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 210033647 | 210028126 | null | null | Curative (C) | 2015-02-06 | 2015-05-14 | Irinotecan + Temozolomide | N | null | 210042033 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 210033648 | 210022530 | null | 99.8 | Palliative (P) | null | 2015-07-15 | Trastuzumab emtansine (Kadcyla) 1st | 0 | null | 210042066 | HYDROXYCARBAMIDE |
| 210033649 | 210022531 | 1.61 | 0 | Palliative (P) | 2015-04-07 | 2016-09-09 | Bevacizumab + Irinotecan | Y | N | 210042069 | CARBO + ETOPOSIDE + VINCRISTINE |
| 210033650 | 210022533 | 1.58 | 58.3 | Palliative (P) | null | 2017-10-28 | DA | N | null | 210042072 | CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 210033651 | 210013663 | 1.7 | 78 | Palliative (P) | 2016-02-10 | 2016-10-26 | Hydroxycarbamide | Y | N | 210042133 | RCEOP |
| 210033652 | 210013667 | 1.57 | 66.6 | Palliative (P) | 2018-03-02 | 2018-03-07 | MELPHALAN | N | N | 210042147 | UKALL 60+ TRIAL |
| 210033653 | 210013672 | 1.6 | null | Curative (C) | 2017-02-25 | 2017-03-02 | Hydroxycarbamide | Y | N | 210042169 | FLUDARABINE |
| 210033654 | 210013673 | 1.79 | null | Curative (C) | 2018-12-05 | 2018-12-05 | CVP R + GEMCITABINE | N | N | 210000284 | FMD |